Search Results for: tuberculosis
Life expectancy has increased, particularly in low income countries, but COVID-19 threatens to throw progress off track, according to the World Health Organization’s annual roundup of worldwide disease and mortality trends. “The good news is that people around the world are living longer and healthier lives. The bad news is the rate of progress is […] Continue reading ->
In the largest global collaboration to address the COVID-19 crisis so far, the World Health Organization, European Commission, and other partners including the Bill and Melinda Gates Foundation (BMGF), launched a new campaign to accelerate development of COVID-19 diagnostics, drugs, and vaccines – and just as critically ensure that they are affordable and accessible worldwide. […] Continue reading ->
While much of the public fanfare around new COVID-19 drugs has centered around the lupus drug, hydroxychloroquine, and a failed Ebola remedy, remdesivir, other researchers are keen to explore the potential of other time-worn remedies – although here, too, experts are urging extreme caution.    Ivermectin, the antiparasitic drug that turned the tide in the […] Continue reading ->
The European Medicines Agency on Friday issued new guidance supporting the use of Gilead Sciences’ antiviral remdesivir as a COVID-19 treatment under compassionate use programmes. The new EMA guidelines on remdesivir recommend its compassionate use  in adult COVID-19 patients experiencing severe disease requiring invasive mechanical ventilation. Such compassionate use programmes are set up by individual […] Continue reading ->
Some 33 Members of the European Parliament released an open letter Friday urging top leadership in the European Commission (EC) to prohibit exclusive licensing for COVID-19 products developed with European Union (EU) grants, and demanding transparency in the research and development pipeline to ensure affordability commitments are met.  In a separate letter signed by 37 […] Continue reading ->

Warning: Attempt to read property "post_title" on null in /home/clients/58f2a29976672af522a8f4d82ffa28b6/web/wp-content/plugins/better-image-credits/better-image-credits.php on line 227
In normal times, Diego Zapata, undersecretary in the City of Medellin’s Mobility Department, worries about how to advance better public transit systems, cycling and pedestrian networks – to get more people moving around the city. But recently, he and his boss Carlos Cadena began supporting the City’s Health Department in its scramble to reduce travel […] Continue reading ->
US Food & Drug Administration authorization of a rapid COVID-19 test on the GeneXpert platform, one of the most widely-used TB diagnostic tools in the world, could be the first crack in the doorway to wider testing capacity in low- and middle-income countries, leading TB advocates told Health Policy Watch.  There are some 23,000 GeneXpert […] Continue reading ->
As the COVID-19 crisis seeps into financial markets, corporate board rooms, and global health systems, there may be one silver lining in an otherwise dark cloud. The 21st century era of digital health, virtual meetings and teleworking is upon us. Countries as far-flung as the Republic of Korea, Israel and even some forward-looking US health […] Continue reading ->
Contact Us
info@healthpolicy-watch.org
1-5 Route des Morillions CP 2100
Geneva 1211, Switzerland
+41 22 791 67 28
About
Privacy Policy
Archives
Staff Access
Log in
Entries RSS
Comments RSS
Wordpress.org
Supported by
Copyright c 2020 Global Policy Reporting